People are at the heart of everything we do, and Prime people make our business uniquely successful.
We are thrilled to announce the arrival of Gordon Muir-Jones to our team. Gordon is both highly regarded and experienced, having been directly involved in the development and implementation of multiple global and domestic medical communications projects for over 30 years.
We are thrilled to announce the acquisition of Aventine Consulting LLC.
Aventine Consulting LLC, founded by Holly Trautman and Jamie Dunning in 2008, is a US-based consulting firm specialising in US-focused market access and payer communications.
Joining forces with Aventine will enable Prime to offer a full spectrum of health economics, market access, value communications and evidence services. Importantly, providing a local US presence to geographically support US-based global clients and meet the increasing needs of the US domestic market.
Caregivers represent an integral part of patient care, yet their vital role is easily overlooked, and they often lack the informational support needed to provide optimal care for patients. For National Caregiver Month (November), Prime Patient explores how pharmaceutical companies can become “caregiver champions” by recognising the essential nature of carers’ roles and providing much needed educational support services (1).
In recognition of both Health Literacy Month and Breast Cancer Awareness Month, we’re looking at the unmet treatment education needs of people living with breast cancer who experience low health literacy.
October is World Breast Cancer Awareness Month, and 13 October is Metastatic Breast Cancer Awareness Day. Let’s look at how the views of people living with metastatic breast cancer provide a vital, underestimated component of assessing the benefits of novel treatments.
Prime Global, a recognised global leader in medical communications, evidence and access, and patient engagement, has acquired earthware, an award-winning creative digital agency that creates life-changing solutions to real world healthcare problems. earthware joins Prime Global in supporting pharma and biotech clients at every step of the healthcare journey; their industry-leading technology expertise will complement Prime Global’s scientific heritage and proven delivery, enhancing and expanding Prime Global’s existing digital capabilities.
At Prime Global, we are passionate about ensuring our operations are sustainable. We are proud to be working together with travel supplier Gray Dawes, in partnership with Forest Carbon, to provide our people with an international carbon offset programme for all business travel.
An estimated 57.4 million people live with dementia worldwide, (1) and unfortunately, clinical trials for dementia treatments have resulted in few pharmacotherapies – none of them curative. (2) (3) (4) For World Alzheimer’s Day, Prime Patient explore how Pharma can collaborate with people living with dementia to optimise the industry’s dementia research and patient community support.
The working day accounts for a lot of our time. On average, over a third of people’s days are spent at work. Because of this, it is extremely important we ensure we are spending this time in a place that is enjoyable and rewarding to work at.
Many agree that disability inclusion in clinical trials is a worthy pursuit, but the historical significance and future impact of pursuing this goal is relatively unexplored. Here, we peel back the layers of this vital mission.
At Prime Global, we are committed to supporting charities and causes that have a direct impact on our communities. This year, we organised the Prime Global Walking Challenge, a virtual walking challenge as part of our ESG initiative to help raise money for the Rainforest Action Network.
A very warm welcome to the latest cohort of our entry-level training programme, IGNITE. This marks the seventh round since the programme’s inception in 2017, and features trainees across our Medical Communications and Evidence, Access, and Patient practice areas.
This month, the results of the 2021 PatientView corporate reputation survey were released. With insights from 240 US patient groups, a number of key findings were reported; here, we take a closer look.
On May 24th, the Prime Patient teamwas fortunate to have a spot at 2022’s Patient Centricity and Engagement Conference, hosted in London, England. With a veritable smorgasbord of topics up for discussion, we were spoiled for choice! Here we summarise some highlights from the day, kicking off with tips on strengthening patient advocacy collaboration.
Haemophilia is a lifelong genetic disorder characterised by excessive bleeding.(1) Despite the existence of treatments for haemophilia, the condition continues to have major impacts on quality of life, for example in the areas of pain (acute and chronic), joint mobility, and physical function.(1) To mark World Haemophilia Day on 17 April, Prime Patient partnered with sister agency HCD Economics, a consultancy specialising in haemophilia patient research, and haemophilia advocate Laurence Woollard to better understand the existing relationship between patients and industry and how meaningful improvements can be made to the lives of people living with haemophilia (PwH).
Patient advocacy and engagement are important no matter the disease area, whether it’s a common condition or one that few have heard of. Following the recent celebration of Rare Disease Day, let’s take a closer look at patient engagement in rare mutation cancers.